Resumen

DAL LAGO, Javier E  y  LEVY, Eduardo J. Osteomielitis de tibia secundaria a la vacuna BCG en un paciente pediátrico inmunocompetente: Reporte de un caso. Rev. Asoc. Argent. Ortop. Traumatol. [online]. 2020, vol.85, n.2, pp.157-166. ISSN 1852-7434.

Introduction: The Bacillus Calmette-Guérin (BCG) vaccine, used to prevent severe forms of tuberculosis (TB), is the most extensively used vaccine worldwide. Adverse events associated with BCG vaccination are rare, and most of them occur at the inoculation site. We present a tibia Osteomyelitis case secondary to BCG vaccination in an immunocompetent infant. Conclusions: Bone involvement secondary to BCG vaccination in previously healthy patients is extremely rare. Healthcare providers must consider such settings in order to make the diagnosis and institute the appropriate treatment. Antituberculous drugs produced good therapeutic results with no need for surgical toilette.

Palabras clave : Tuberculosis; TB; Bacillus Calmette-Guérin; BCG; Osteomyelitis; Osteitis.

        · resumen en Español     · texto en Español     · Español ( pdf )